|
FR2751227B1
(fr)
*
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
|
|
US7294338B2
(en)
*
|
1996-07-19 |
2007-11-13 |
Merial |
Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
|
|
EP0863151A1
(en)
*
|
1997-02-12 |
1998-09-09 |
Akzo Nobel N.V. |
"Canine parvovirus dna vaccines"
|
|
CA2223029A1
(en)
*
|
1997-02-12 |
1998-08-12 |
Akzo Nobel Nv |
Canine parvovirus dna vaccines
|
|
US6368603B1
(en)
*
|
1997-03-05 |
2002-04-09 |
Merial Limited |
Lyme combination compositions and uses
|
|
FR2794648B1
(fr)
*
|
1999-06-10 |
2003-03-07 |
Merial Sas |
Vaccins adn pour animaux de compagnie et de sport
|
|
BR0011732B1
(pt)
*
|
1999-06-10 |
2014-02-04 |
|
Vacinas de dna para animais de companhia e de esporte
|
|
CN1245217C
(zh)
*
|
2001-02-15 |
2006-03-15 |
雷吉斯特印度科学院 |
一种包含dna疫苗和灭活狂犬病毒的疫苗制剂
|
|
FR2823222B1
(fr)
|
2001-04-06 |
2004-02-06 |
Merial Sas |
Vaccin contre le virus de la fievre du nil
|
|
US7906311B2
(en)
|
2002-03-20 |
2011-03-15 |
Merial Limited |
Cotton rat lung cells for virus culture
|
|
AU2003299780A1
(en)
*
|
2002-12-19 |
2004-07-14 |
Akzo Nobel Patent Department |
Trivalent vaccine with maternal antibody transfer via the milk
|
|
EP2390352A1
(en)
|
2003-03-18 |
2011-11-30 |
Quantum Genetics Ireland Limited |
Systems and methods for improving protein and milk production of dairy herds
|
|
US7468273B2
(en)
|
2003-05-01 |
2008-12-23 |
Meial Limited |
Canine GHRH gene, polypeptides and methods of use
|
|
AU2004269320B2
(en)
|
2003-06-20 |
2009-12-24 |
Protein Sciences Corporation |
Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
|
|
EP1689858B1
(en)
|
2003-11-13 |
2013-05-15 |
University Of Georgia Research Foundation, Inc. |
Methods of characterizing infectious bursal disease virus
|
|
MXPA06009452A
(es)
|
2004-02-19 |
2007-03-15 |
Univ Alberta |
Polimorfismos del promotor de leptin y sus usos.
|
|
SI1881845T1
(sl)
|
2005-04-25 |
2010-06-30 |
Merial Ltd |
Cepiva proti virusu Nipah
|
|
US20080241184A1
(en)
|
2005-08-25 |
2008-10-02 |
Jules Maarten Minke |
Canine influenza vaccines
|
|
EP1951751B1
(en)
|
2005-11-14 |
2017-11-01 |
Merial, Inc. |
Gene therapy for renal failure
|
|
US7771995B2
(en)
|
2005-11-14 |
2010-08-10 |
Merial Limited |
Plasmid encoding human BMP-7
|
|
US7767686B2
(en)
*
|
2006-03-03 |
2010-08-03 |
Covidien Ag |
Method of using adenosine receptor blockers during tissue ablation
|
|
AU2007233252C1
(en)
|
2006-03-29 |
2013-05-23 |
Boehringer Ingelheim Animal Health USA Inc. |
Vaccine against Streptococci
|
|
US7862821B2
(en)
|
2006-06-01 |
2011-01-04 |
Merial Limited |
Recombinant vaccine against bluetongue virus
|
|
US20080274137A1
(en)
*
|
2007-05-02 |
2008-11-06 |
Jean Christophe Francis Audonnet |
DNA plasmids having improved expression and stability
|
|
KR101445903B1
(ko)
|
2007-05-02 |
2014-09-29 |
메리얼 리미티드 |
향상된 발현 및 안정성을 갖는 ｄｎａ 플라스미드
|
|
MX2011005604A
(es)
|
2008-11-28 |
2011-09-01 |
Merial Ltd |
Vacuna recombinante para influenza aviar y sus usos.
|
|
JP5797636B2
(ja)
|
2009-04-03 |
2015-10-21 |
メリアル リミテッド |
ニューカッスル病ウイルスをベクターとするトリワクチン
|
|
WO2011090708A2
(en)
|
2009-12-28 |
2011-07-28 |
Merial Limited |
Recombinant ndv antigen and uses thereof
|
|
US20130197612A1
(en)
|
2010-02-26 |
2013-08-01 |
Jack W. Lasersohn |
Electromagnetic Radiation Therapy
|
|
US9345759B2
(en)
|
2010-03-12 |
2016-05-24 |
Merial, Inc. |
Bluetongue virus recombinant vaccines and uses thereof
|
|
JP5913316B2
(ja)
|
2010-08-31 |
2016-04-27 |
メリアル リミテッド |
ニューカッスル病ウイルスをベクターとするヘルペスウイルスワクチン
|
|
WO2012090073A2
(en)
|
2010-12-30 |
2012-07-05 |
The Netherlands Cancer Institute |
Methods and compositions for predicting chemotherapy sensitivity
|
|
EP2694677A2
(en)
|
2011-04-04 |
2014-02-12 |
Netherland Cancer Institute |
Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
|
|
AU2012240246A1
(en)
|
2011-04-04 |
2013-05-09 |
Netherlands Cancer Institute |
Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
|
|
US9216213B2
(en)
|
2011-04-20 |
2015-12-22 |
Merial, Inc. |
Adjuvanted rabies vaccine with improved viscosity profile
|
|
KR102007444B1
(ko)
|
2011-04-25 |
2019-08-06 |
어드밴스드 바이오사이언스 라보라토리즈, 인코포레이티드 |
절단형 hiv 피막 단백질(env), 이와 관련된 방법 및 조성물
|
|
NZ618125A
(en)
|
2011-05-27 |
2016-03-31 |
Merial Ltd |
Genetic vaccines against hendra virus and nipah virus
|
|
ES2674439T3
(es)
|
2011-06-01 |
2018-06-29 |
Merial, Inc. |
Administración sin aguja de vacunas contra el VSRRP
|
|
US10166188B2
(en)
|
2011-08-12 |
2019-01-01 |
Merial, Inc. |
Method for vacuum-assisted preservation of biologics including vaccines
|
|
EP2586461A1
(en)
|
2011-10-27 |
2013-05-01 |
Christopher L. Parks |
Viral particles derived from an enveloped virus
|
|
WO2013093629A2
(en)
|
2011-12-20 |
2013-06-27 |
Netherlands Cancer Institute |
Modular vaccines, methods and compositions related thereto
|
|
US9567606B2
(en)
|
2012-02-14 |
2017-02-14 |
Merial Inc. |
Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom
|
|
JP6149240B2
(ja)
|
2012-02-14 |
2017-06-21 |
メリアル インコーポレイテッド |
ロタウイルスサブユニットワクチン並びにその製造及び使用方法
|
|
WO2013138776A1
(en)
|
2012-03-16 |
2013-09-19 |
Merial Limited |
Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
|
|
US9347065B2
(en)
|
2012-03-29 |
2016-05-24 |
International Aids Vaccine Initiative |
Methods to improve vector expression and genetic stability
|
|
CA2876196C
(en)
|
2012-06-13 |
2021-09-21 |
Merial Limited |
Reassortant btv vaccines
|
|
US20140170180A1
(en)
|
2012-12-17 |
2014-06-19 |
Boehringer Ingelheim Vetmedica, Inc. |
Porcine parvovirus 5a, methods of use and vaccine
|
|
US20140234354A1
(en)
|
2013-02-15 |
2014-08-21 |
Boehringer Ingelheim Vetmedica, Inc. |
Porcine parvovirus 5b, methods of use and vaccine
|
|
HK1216006A1
(zh)
|
2013-03-12 |
2016-10-07 |
Boehringer Ingelheim Animal Health USA Inc. |
反向遺傳學施馬倫貝格病毒疫苗組合物，和其使用方法
|
|
CN110195072A
(zh)
*
|
2013-08-21 |
2019-09-03 |
库瑞瓦格股份公司 |
狂犬病疫苗
|
|
WO2015077717A1
(en)
|
2013-11-25 |
2015-05-28 |
The Broad Institute Inc. |
Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
|
|
US11725237B2
(en)
|
2013-12-05 |
2023-08-15 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
|
EP3082853A2
(en)
|
2013-12-20 |
2016-10-26 |
The Broad Institute, Inc. |
Combination therapy with neoantigen vaccine
|
|
US10010499B2
(en)
|
2014-11-03 |
2018-07-03 |
Merial Inc. |
Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
|
|
WO2016100975A1
(en)
|
2014-12-19 |
2016-06-23 |
Massachsetts Institute Ot Technology |
Molecular biomarkers for cancer immunotherapy
|
|
WO2016100977A1
(en)
|
2014-12-19 |
2016-06-23 |
The Broad Institute Inc. |
Methods for profiling the t-cel- receptor repertoire
|
|
CR20200476A
(es)
|
2015-05-20 |
2020-12-02 |
Dana Farber Cancer Inst Inc |
ANTÍGENOS COMPARTIDOS (Divisional 2017-0584)
|
|
TW202241500A
(zh)
|
2015-06-09 |
2022-11-01 |
美商博德研究所有限公司 |
用於贅瘤疫苗之調配物及其製備方法
|
|
WO2016210094A1
(en)
|
2015-06-23 |
2016-12-29 |
Merial, Inc. |
Prrsv minor protein-containing recombinant viral vectors and methods of making and use thereof
|
|
EP3337503A1
(en)
|
2015-08-20 |
2018-06-27 |
Merial, Inc. |
Fcv recombinant vaccines and uses thereof
|
|
AR106026A1
(es)
|
2015-09-29 |
2017-12-06 |
Merial Inc |
Vacunas de partículas tipo virus (vlp) contra el parvovirus canino (cpv) y sus usos
|
|
KR102153303B1
(ko)
|
2015-11-23 |
2020-09-09 |
뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 |
Fmdv 및 e2 융합 단백질 및 이의 용도
|
|
RU2626605C2
(ru)
*
|
2015-11-25 |
2017-07-28 |
Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) |
Генетическая (рекомбинантная) ДНК-конструкция, содержащая кодон-оптимизированный ген гликопротеина (белка G) вируса бешенства с консенсусной аминокислотной последовательностью, которая составлена с учетом аминокислотных последовательностей белка G, выделяемого из штаммов вируса бешенства, циркулирующих на территории Российской Федерации
|
|
TWI760322B
(zh)
|
2016-01-29 |
2022-04-11 |
美商百靈佳殷格翰動物保健美國有限公司 |
重組腺病毒載體裝載之fmdv疫苗及其用途
|
|
EP3446119A1
(en)
|
2016-04-18 |
2019-02-27 |
The Broad Institute Inc. |
Improved hla epitope prediction
|
|
WO2018140391A1
(en)
|
2017-01-24 |
2018-08-02 |
The Broad Institute, Inc. |
Compositions and methods for detecting a mutant variant of a polynucleotide
|
|
CN108704128B
(zh)
*
|
2018-05-15 |
2022-06-21 |
青岛农业大学 |
一种犬瘟热细小病毒二联亚单位疫苗
|
|
US20210382068A1
(en)
|
2018-10-02 |
2021-12-09 |
Dana-Farber Cancer Institute, Inc. |
Hla single allele lines
|
|
US20220062394A1
(en)
|
2018-12-17 |
2022-03-03 |
The Broad Institute, Inc. |
Methods for identifying neoantigens
|
|
RU2707544C1
(ru)
*
|
2018-12-28 |
2019-11-27 |
Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) |
Генетическая конструкция на основе оптимизированного гена консенсусного гликопротеина вируса бешенства для профилактики бешенства
|
|
US12394502B2
(en)
|
2019-10-02 |
2025-08-19 |
The General Hospital Corporation |
Method for predicting HLA-binding peptides using protein structural features
|
|
CN116735873B
(zh)
*
|
2023-08-09 |
2023-10-31 |
北京纳百生物科技有限公司 |
特异性结合犬细小病毒vp2蛋白的单克隆抗体在检测试剂中的应用
|